Cargando…

Spending and Hospital Stay for Melanoma in Hunan, China

OBJECTIVE: This study aimed to describe the economic burden of Chinese patients with melanoma in Hunan province of China, and to investigate the factors for hospitalization spending and length of stay (LOS) in patients undergoing melanoma surgery. METHODS: Data was extracted from the Chinese Nationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Xinchen, Lin, Wenrui, Li, Daishi, Zhao, Shuang, Chen, Mingliang, Xiao, Yi, Chen, Xiang, Shen, Minxue, Su, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343693/
https://www.ncbi.nlm.nih.gov/pubmed/35928495
http://dx.doi.org/10.3389/fpubh.2022.917119
_version_ 1784761044944551936
author Ke, Xinchen
Lin, Wenrui
Li, Daishi
Zhao, Shuang
Chen, Mingliang
Xiao, Yi
Chen, Xiang
Shen, Minxue
Su, Juan
author_facet Ke, Xinchen
Lin, Wenrui
Li, Daishi
Zhao, Shuang
Chen, Mingliang
Xiao, Yi
Chen, Xiang
Shen, Minxue
Su, Juan
author_sort Ke, Xinchen
collection PubMed
description OBJECTIVE: This study aimed to describe the economic burden of Chinese patients with melanoma in Hunan province of China, and to investigate the factors for hospitalization spending and length of stay (LOS) in patients undergoing melanoma surgery. METHODS: Data was extracted from the Chinese National Health Statistics Network Reporting System database in Hunan province during 2017–2019. Population and individual statistics were presented, and nonparametric tests and quantile regression were used to analyze the factors for spending and LOS. RESULT: A total of 2,644 hospitalized patients with melanoma in Hunan were identified. During 2017–2019, the total hospitalization spending was $5,247,972, and out-of-pocket payment (OOP) was $1,817,869, accounting for 34.6% of the total expenditure. The median spending was $1,123 [interquartile range (IQR): $555–2,411] per capita, and the median LOS was 10 days (IQR: 5–18). A total of 1,104 patients who underwent surgery were further analyzed. The non-parametric tests and quantile regression showed that women were associated with less spending and LOS than men. In general, patients aged 46–65 and those with lesions on the limbs had higher hospitalization costs and LOS than other subgroups. CONCLUSION: Melanoma causes heavy economic burdens on patients in Hunan, such that the median spending is close to 60% of the averagely annual disposable income. Middle-aged men patients with melanoma on the limbs present the highest financial burden of melanoma.
format Online
Article
Text
id pubmed-9343693
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93436932022-08-03 Spending and Hospital Stay for Melanoma in Hunan, China Ke, Xinchen Lin, Wenrui Li, Daishi Zhao, Shuang Chen, Mingliang Xiao, Yi Chen, Xiang Shen, Minxue Su, Juan Front Public Health Public Health OBJECTIVE: This study aimed to describe the economic burden of Chinese patients with melanoma in Hunan province of China, and to investigate the factors for hospitalization spending and length of stay (LOS) in patients undergoing melanoma surgery. METHODS: Data was extracted from the Chinese National Health Statistics Network Reporting System database in Hunan province during 2017–2019. Population and individual statistics were presented, and nonparametric tests and quantile regression were used to analyze the factors for spending and LOS. RESULT: A total of 2,644 hospitalized patients with melanoma in Hunan were identified. During 2017–2019, the total hospitalization spending was $5,247,972, and out-of-pocket payment (OOP) was $1,817,869, accounting for 34.6% of the total expenditure. The median spending was $1,123 [interquartile range (IQR): $555–2,411] per capita, and the median LOS was 10 days (IQR: 5–18). A total of 1,104 patients who underwent surgery were further analyzed. The non-parametric tests and quantile regression showed that women were associated with less spending and LOS than men. In general, patients aged 46–65 and those with lesions on the limbs had higher hospitalization costs and LOS than other subgroups. CONCLUSION: Melanoma causes heavy economic burdens on patients in Hunan, such that the median spending is close to 60% of the averagely annual disposable income. Middle-aged men patients with melanoma on the limbs present the highest financial burden of melanoma. Frontiers Media S.A. 2022-07-19 /pmc/articles/PMC9343693/ /pubmed/35928495 http://dx.doi.org/10.3389/fpubh.2022.917119 Text en Copyright © 2022 Ke, Lin, Li, Zhao, Chen, Xiao, Chen, Shen and Su. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Ke, Xinchen
Lin, Wenrui
Li, Daishi
Zhao, Shuang
Chen, Mingliang
Xiao, Yi
Chen, Xiang
Shen, Minxue
Su, Juan
Spending and Hospital Stay for Melanoma in Hunan, China
title Spending and Hospital Stay for Melanoma in Hunan, China
title_full Spending and Hospital Stay for Melanoma in Hunan, China
title_fullStr Spending and Hospital Stay for Melanoma in Hunan, China
title_full_unstemmed Spending and Hospital Stay for Melanoma in Hunan, China
title_short Spending and Hospital Stay for Melanoma in Hunan, China
title_sort spending and hospital stay for melanoma in hunan, china
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343693/
https://www.ncbi.nlm.nih.gov/pubmed/35928495
http://dx.doi.org/10.3389/fpubh.2022.917119
work_keys_str_mv AT kexinchen spendingandhospitalstayformelanomainhunanchina
AT linwenrui spendingandhospitalstayformelanomainhunanchina
AT lidaishi spendingandhospitalstayformelanomainhunanchina
AT zhaoshuang spendingandhospitalstayformelanomainhunanchina
AT chenmingliang spendingandhospitalstayformelanomainhunanchina
AT xiaoyi spendingandhospitalstayformelanomainhunanchina
AT chenxiang spendingandhospitalstayformelanomainhunanchina
AT shenminxue spendingandhospitalstayformelanomainhunanchina
AT sujuan spendingandhospitalstayformelanomainhunanchina